跳至主要内容
临床试验/CTRI/2021/08/035736
CTRI/2021/08/035736
尚未招募
2 期

Role of Incentive Spirometry in pulmonary rehabilitation of severe COVID-19 patients- an open label randomised controlled trial - RISE COVID

Dr Animesh Ray0 个研究点目标入组 0 人待定

概览

阶段
2 期
干预措施
未指定
疾病 / 适应症
未指定
发起方
Dr Animesh Ray
状态
尚未招募
最后更新
4年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
4年前
研究类型
Interventional

研究者

发起方
Dr Animesh Ray

入排标准

入选标准

  • a) Aged at least 18 years
  • b) Hospitalised
  • c) Confirmed SARS\-CoV\-2 infection by nucleic acid based testing (RT\-PCR, CB\-NAAT, or TrueNAT) or antigen testing
  • d) Moderate and severe COVID\-19 pneumonia (SpO2 \<94%)
  • e) Decreasing supplemental oxygen requirements (Nasal prongs \<\=6 L/min)
  • f) Hemodynamically stable
  • g) Cooperative
  • h) No medical history that might, in the opinion of the attending clinician, put the patient at significant risk if he/she were to participate in the trial

排除标准

  • a) MMSE \<24
  • b) Recent surgery, cardiovascular event (ACS, PE)
  • c) Moderate\-severe heart disease (NYHA grade III or IV)
  • d) CLD with ascites
  • e) Prior history of TB, COPD, asthma, ILD
  • f) Pregnant and lactating women
  • g) Difficulty in mobilisation (for 6MWT)
  • h) Hemodynamically unstable
  • i) Refusal of consent

结局指标

主要结局

未指定

相似试验